pcDNA3.1-TK1 Citations (1)

Originally described in: Pyrimidine metabolic rate limiting enzymes in poorly-differentiated hepatocellular carcinoma are signature genes of cancer stemness and associated with poor prognosis.
Yeh HW, Lee SS, Chang CY, Hu CM, Jou YS Oncotarget. 2017 Sep 8;8(44):77734-77751. doi: 10.18632/oncotarget.20774. eCollection 2017 Sep 29. PubMed Journal

---

Articles Citing pcDNA3.1-TK1

Articles
Optimization of a Novel 2 + 2 BCMA x CD3 Bispecific Antibody for Minimized Cytokine Release and Potent Efficacy. Wu D, Huang L, Naren G, Zhang R, Gong S, Wu X, Wu C. Mol Cancer Ther. 2025 Oct 1;24(10):1600-1610. doi: 10.1158/1535-7163.MCT-24-0846. PubMed

If you have published an article using this material, please email us at to have your article added to this page.